Raffo A - Search Results

1

Gene Therapy with p14/tBID Induces Selective and Synergistic Apoptosis in Mutant Ras and Mutant p53 Cancer Cells In Vitro and In Vivo.

Fine RL, Mao Y, Garcia-Carracedo D, Su GH, Qiu W, Hochfeld U, Nichols G, Li YL, Dinnen RD, Raffo A, Brandt-Rauf PW. Fine RL, et al. Among authors: raffo a. Biomedicines. 2023 Jan 18;11(2):258. doi: 10.3390/biomedicines11020258. Biomedicines. 2023. PMID: 36830797 Free PMC article.

2

C-Terminal p53 Palindromic Tetrapeptide Restores Full Apoptotic Function to Mutant p53 Cancer Cells In Vitro and In Vivo.

Fine RL, Mao Y, Dinnen R, Rosal RV, Raffo A, Hochfeld U, Senatus P, Bruce JN, Nichols G, Wang H, Li Y, Brandt-Rauf PW. Fine RL, et al. Among authors: raffo a. Biomedicines. 2023 Jan 5;11(1):137. doi: 10.3390/biomedicines11010137. Biomedicines. 2023. PMID: 36672645 Free PMC article.

3

Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells.

Kim AL, Raffo AJ, Brandt-Rauf PW, Pincus MR, Monaco R, Abarzua P, Fine RL. Kim AL, et al. Among authors: raffo aj. J Biol Chem. 1999 Dec 3;274(49):34924-31. doi: 10.1074/jbc.274.49.34924. J Biol Chem. 1999. PMID: 10574967 Free article.

4

Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.

Li Y, Raffo AJ, Drew L, Mao Y, Tran A, Petrylak DP, Fine RL. Li Y, et al. Among authors: raffo aj. Cancer Res. 2003 Apr 1;63(7):1527-33. Cancer Res. 2003. PMID: 12670900

5

Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.

Raffo AJ, Kim AL, Fine RL. Raffo AJ, et al. Oncogene. 2000 Dec 14;19(54):6216-28. doi: 10.1038/sj.onc.1203995. Oncogene. 2000. PMID: 11175336

6

Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site.

Do TN, Rosal RV, Drew L, Raffo AJ, Michl J, Pincus MR, Friedman FK, Petrylak DP, Cassai N, Szmulewicz J, Sidhu G, Fine RL, Brandt-Rauf PW. Do TN, et al. Oncogene. 2003 Mar 13;22(10):1431-44. doi: 10.1038/sj.onc.1206258. Oncogene. 2003. PMID: 12629507

7

Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells.

Kanovsky M, Raffo A, Drew L, Rosal R, Do T, Friedman FK, Rubinstein P, Visser J, Robinson R, Brandt-Rauf PW, Michl J, Fine RL, Pincus MR. Kanovsky M, et al. Among authors: raffo a. Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12438-43. doi: 10.1073/pnas.211280698. Epub 2001 Oct 16. Proc Natl Acad Sci U S A. 2001. PMID: 11606716 Free PMC article.

8

Antisense RNA down-regulation of bcl-2 expression in DU145 prostate cancer cells does not diminish the cytostatic effects of G3139 (Oblimersen).

Raffo A, Lai JC, Stein CA, Miller P, Scaringe S, Khvorova A, Benimetskaya L. Raffo A, et al. Clin Cancer Res. 2004 May 1;10(9):3195-206. doi: 10.1158/1078-0432.ccr-03-0287. Clin Cancer Res. 2004. PMID: 15131061

9

Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.

Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R. Raffo AJ, et al. Cancer Res. 1995 Oct 1;55(19):4438-45. Cancer Res. 1995. PMID: 7671257

10

Visualizing pancreatic beta-cell mass with [11C]DTBZ.

Simpson NR, Souza F, Witkowski P, Maffei A, Raffo A, Herron A, Kilbourn M, Jurewicz A, Herold K, Liu E, Hardy MA, Van Heertum R, Harris PE. Simpson NR, et al. Among authors: raffo a. Nucl Med Biol. 2006 Oct;33(7):855-64. doi: 10.1016/j.nucmedbio.2006.07.002. Nucl Med Biol. 2006. PMID: 17045165 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page